Cognitive improvement during Tolcapone treatment in Parkinson's disease. (Q52044607)

20 April 2018

http://europepmc.org/abstract/MED/9451720

title

Cognitive improvement during Tolcapone treatment in Parkinson's disease. (English)

1 reference

20 April 2018

http://europepmc.org/abstract/MED/9451720

1 reference

4

G Meco

1 reference

20 April 2018

1

M Gasparini

1 reference

20 April 2018

http://europepmc.org/abstract/MED/9451720

E Fabrizio

series ordinal

2

object named as

E Fabrizio

1 reference

20 April 2018

http://europepmc.org/abstract/MED/9451720

Vincenzo Bonifati

series ordinal

3

object named as

V Bonifati

1 reference

20 April 2018

http://europepmc.org/abstract/MED/9451720

publication date

1 January 1997

1 reference

20 April 2018

http://europepmc.org/abstract/MED/9451720

published in

Journal of Neural Transmission

1 reference

20 April 2018

http://europepmc.org/abstract/MED/9451720

volume

104

1 reference

20 April 2018

http://europepmc.org/abstract/MED/9451720

issue

8-9

1 reference

20 April 2018

http://europepmc.org/abstract/MED/9451720

page(s)

887-894

1 reference

20 April 2018

http://europepmc.org/abstract/MED/9451720

cites work

Fluctuations in plasma dopamine level impair memory in Parkinson's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9451720

12 December 2020

Locus coeruleus stimulation decreases deoxyglucose uptake in ipsilateral mouse cerebral cortex

1 reference

https://pubmed.ncbi.nlm.nih.gov/9451720

12 December 2020

Fronto-striatal cognitive deficits at different stages of Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/9451720

12 December 2020

Ro 40-7592, a novel, very potent, and orally active inhibitor of catechol-O-methyltransferase: a pharmacological study in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/9451720

12 December 2020

Auditory attention in early Parkinson's disease: An impairment in focused attention

1 reference

https://pubmed.ncbi.nlm.nih.gov/9451720

12 December 2020

Cognitive concomitants of dopamine system stimulation in parkinsonian patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/9451720

12 December 2020

Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/9451720

12 December 2020

Impaired simultaneous cognitive task performance in Parkinson's disease: a dopamine-related dysfunction

1 reference

https://pubmed.ncbi.nlm.nih.gov/9451720

12 December 2020

Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?

1 reference

https://pubmed.ncbi.nlm.nih.gov/9451720

12 December 2020

Cognitive slowing in decision tasks in early and advanced Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/9451720

12 December 2020

Norepinephrine-containing locus coeruleus neurons in behaving rats exhibit pronounced responses to non-noxious environmental stimuli.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9451720

12 December 2020

Parkinson's disease and dementia: norepinephrine and dopamine in locus ceruleus

1 reference

https://pubmed.ncbi.nlm.nih.gov/9451720

12 December 2020

Alterations in cognitive performance and affect-arousal state during fluctuations in motor function in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/9451720

12 December 2020

'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa

1 reference

https://pubmed.ncbi.nlm.nih.gov/9451720

12 December 2020

Visuospatial memory deficits at different stages of Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/9451720

12 December 2020

Selegiline and cognitive function in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/9451720

12 December 2020

Dose-dependent memory impairment in Parkinson's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9451720

12 December 2020

Role of monoamine pathways in the control of attention: effects of droperidol and methylphenidate in normal adult humans.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9451720

12 December 2020

Cognitive impairments in Parkinson's disease: distinguishing between effort-demanding and automatic cognitive processes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9451720

12 December 2020

Dementia in Parkinson disease: a neuropsychological analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9451720

12 December 2020

Working memory in medicated patients with Parkinson's disease: the central executive seems to work

1 reference

https://pubmed.ncbi.nlm.nih.gov/9451720

12 December 2020

Specific impairments of planning

1 reference

https://pubmed.ncbi.nlm.nih.gov/9451720

12 December 2020

Catecholamines and the covert orientation of attention in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/9451720

12 December 2020

Dopamine and memory function in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/9451720

12 December 2020

Cognitive fluctuations associated with on-off phenomenon in Parkinson disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/9451720

12 December 2020

Identifiers

DOI

10.1007/BF01285556

1 reference

20 April 2018

http://europepmc.org/abstract/MED/9451720

1 reference

20 April 2018